Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kirschner

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Plos Genetics|December 20, 2015
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMichele Carbone, Erin G Flores, Mitsuru Emi, et al.
Oncotarget|July 1, 2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaMarissa Williams, Michaela B Kirschner, Yuen Yee Cheng, et al.
British Journal of Cancer|August 12, 2015
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisMichaela B Kirschner, Emily Pulford, Mir Alireza Hoda, et al.
Carcinogenesis|April 11, 2018
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signalKarin Schelch, Christina Wagner, Sonja Hager, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyMir Alireza Hoda, Yawen Dong, Anita Rozsas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 17, 2022
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
JCO Precision Oncology|February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape ProjectMartina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Communications Psychology|October 7, 2025
Everyday norms have become more permissive over time and vary across culturesKimmo Eriksson, Pontus Strimling, Irina Vartanova, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Plos Genetics|December 20, 2015
Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700sMichele Carbone, Erin G Flores, Mitsuru Emi, et al.
Oncotarget|July 1, 2015
miR-193a-3p is a potential tumor suppressor in malignant pleural mesotheliomaMarissa Williams, Michaela B Kirschner, Yuen Yee Cheng, et al.
British Journal of Cancer|August 12, 2015
Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosisMichaela B Kirschner, Emily Pulford, Mir Alireza Hoda, et al.
Carcinogenesis|April 11, 2018
FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signalKarin Schelch, Christina Wagner, Sonja Hager, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2016
Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional studyMir Alireza Hoda, Yawen Dong, Anita Rozsas, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 17, 2022
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 17, 2022
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape projectJan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, et al.
JCO Precision Oncology|February 12, 2025
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma: Results From the European Thoracic Platform Mesoscape ProjectMartina Haberecker, Jan H Rüschoff, Charitini Andriakopoulou, et al.
Communications Psychology|October 7, 2025
Everyday norms have become more permissive over time and vary across culturesKimmo Eriksson, Pontus Strimling, Irina Vartanova, et al.
Pageof 10